The partnership brings together Pfizer’s scientific data and therapeutic expertise with Boltz’s open-source AI foundation ...
MIT scientists have released a powerful, open-source AI model called Boltz-1 that could significantly accelerate biomedical research and drug development. The paper is available on the bioRxiv ...